Clene's Investor Summit Presentation Highlights Strategic Focus Clene Inc.'s CEO Rob Etherington and CFO Morgan Brown recently presented at the Investor Summit Virtual on March 11, 2025. The biopharmaceutical company, focused on neurodegenerative diseases like ALS, showcased its innovative drug CNM-Au8, which targets mitochondrial health. This presentation aimed to attract microcap investors and highlight growth potential.1